These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8287759)

  • 1. Utility of BER-EP4 in the diagnosis of adenocarcinoma in effusions: an immunocytochemical study of 232 cases.
    Diaz-Arias AA; Loy TS; Bickel JT; Chapman RK
    Diagn Cytopathol; 1993 Oct; 9(5):516-21. PubMed ID: 8287759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4.
    De Angelis M; Buley ID; Heryet A; Gray W
    Cytopathology; 1992; 3(2):111-7. PubMed ID: 1617160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
    Afify A; Zhou H; Howell L; Paulino AF
    Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody Ber-EP4: its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimens.
    Maguire B; Whitaker D; Carrello S; Spagnolo D
    Diagn Cytopathol; 1994; 10(2):130-4. PubMed ID: 8187591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of BCA-225 in the cytologic diagnosis of malignant effusions: an immunocytochemical study of 197 cases.
    Loy TS; Diaz-Arias AA; Bickel JT
    Mod Pathol; 1990 May; 3(3):294-7. PubMed ID: 2194212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of malignant cells in serous effusions using a panel of monoclonal antibodies Ber-EP4, MCA-b-12 and EMA.
    Stoop JA; Hendriks JG; Berends D
    Cytopathology; 1992; 3(5):297-302. PubMed ID: 1288655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
    Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1.
    Bailey ME; Brown RW; Mody DR; Cagle P; Ramzy I
    Acta Cytol; 1996; 40(6):1212-6. PubMed ID: 8960030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
    Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality control of immunocytochemical staining of effusions using a standardized method of cell processing.
    Kuenen-Boumeester V; van Loenen P; de Bruijn EM; Henzen-Logmans SC
    Acta Cytol; 1996; 40(3):475-9. PubMed ID: 8669182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunofluorescent staining of metastatic carcinoma cells in serious fluid with carcinoembryonic antibody, epithelial membrane antibody, AUA-1 and Ber-EP4.
    Illingworth AL; Young JA; Johnson GD
    Cytopathology; 1994 Oct; 5(5):270-81. PubMed ID: 7819512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies in the cytodiagnosis of serous effusions.
    al-Nafussi A; Carder PJ
    Cytopathology; 1990; 1(2):119-28. PubMed ID: 1714782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinction between cells in serous effusions using a panel of antibodies.
    Lauritzen AF
    Virchows Arch A Pathol Anat Histopathol; 1987; 411(3):299-304. PubMed ID: 2441518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks.
    Kim JH; Kim GE; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
    Diagn Cytopathol; 2009 Apr; 37(4):258-61. PubMed ID: 19217030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of HBME-1 immunostaining in serous effusions.
    Ascoli V; Carnovale-Scalzo C; Taccogna S; Nardi F
    Cytopathology; 1997 Oct; 8(5):328-35. PubMed ID: 9313985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of adenocarcinoma in cytospin preparations of effusions using monoclonal antibody B72.3.
    Martin SE; Moshiri S; Thor A; Vilasi V; Chu EW; Schlom J
    Am J Clin Pathol; 1986 Jul; 86(1):10-8. PubMed ID: 3524191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of monoclonal antibodies AUA1 and BER EP4 with anti-CEA for detecting carcinoma cells in serous effusions and distinguishing them from mesothelial cells.
    Robinson RJ; Royston D
    Cytopathology; 1993; 4(5):267-71. PubMed ID: 8274664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical typification of mesothelial cells in effusions: in vivo and in vitro models.
    Ferrandez-Izquierdo A; Navarro-Fos S; Gonzalez-Devesa M; Gil-Benso R; Llombart-Bosch A
    Diagn Cytopathol; 1994; 10(3):256-62. PubMed ID: 7519540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Accuracy of a Limited Immuno-panel of Calretinin and Ber-EP4 for Diagnosis of Malignant Effusions.
    Khurram N; Anis T; Yusuf NW
    J Coll Physicians Surg Pak; 2019 Jan; 29(1):33-36. PubMed ID: 30630566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.